In animal models of pulmonary hypertension, overexpression of the A2BAR has been associated with increased levels of remodelling agents (e.g., IL-6 and matrix metalloproteinases) and signalling molecules implicated in the pathogenesis of PAH, such as endothelin-1 [11]. The gene discussed is IL6; the disease is pulmonary arterial hypertension.